Calendar
2021
-
Future of Work Collaborative
Details
The ALDA Future of Work Collaborative will convene in April to discuss the latest thinking regarding getting back to the office, an issue that has been increasingly in the headlines in recent weeks including announcements from Google, JPM, and others.
ALDA member companies have been focused on this topic for the past year, and on April 20 Nita Hendrickson with BD Biosciences will share BD’s current thinking on this constantly evolving topic. Nita will share how BD is approaching the new normal when it comes to remote work, and expanded return to campus, any permanent changes that may be implemented, short- and longer-term timelines, and more.
We will also be joined by Debra Shoji-Sinkus with PerkinElmer, who will provide a brief update on our vaccination discussion from January, and where PerkinElmer stands in their communications.
The details are:
ALDA Future of Work Collaborative
Tuesday, April 20, 2021
11:00 AM Eastern
“The Future of Work with BD Biosciences & Vaccine Implementation Update with PerkinElmer”Presented by:
Nita Hendrickson
Vice President, Human Resources
BD BiosciencesDebra Shoji-Sinkus
Senior Director, Assistant Corporate Counsel
PerkinElmer -
2021 Virtual Spring Senior Executives Conference: CEO Roundtable: COVID-19 and the Path Forward
Details
The Spring Senior Executives Meeting s one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
This Spring’s program will be virtual over four Thursdays in May and will discuss Pandemics and Infectious Diseases — a timely topic.
Setting the stage for the conference, a panel of prominent industry CEOs will discuss the impact that the COVID pandemic has had on our industry and their organizations, and what it means for the ALDA community. What has our industry learned and how can we build on these lessons moving forward? The group will discuss these and other relevant questions, as determined by attendees.
Featuring:
-
2021 Virtual Spring Senior Executives Conference: An Analytical Retrospective on COVID-19 and Infectious Disease
Details
The Spring Senior Executives Meeting s one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
This Spring’s program will be virtual over four Thursdays in May and will discuss Pandemics and Infectious Diseases — a timely topic.
Thursday, May 13
11:00 AM – 12:30 PM Eastern US
An Analytical Retrospective on COVID-19 and Infectious Disease
Presented by:
.jpg?resize=147%2C160&ssl=1)
- Dr. Pardis Sabeti with the Broad Institute, a professor in the Department of Immunology and Infectious Disease at the Harvard School of Public Health.
Dr. Sabeti, who led the original team that genetically sequenced the Ebola Virus and has been a leader in scientific breakthroughs aimed at stopping the spread of COVID-19, will take a look back at what we have learned from the past year, and discuss opportunities to expand on these lessons in the years ahead.
This session will be followed by topic-based dedicated networking time using our conference software platform. More to come.
-
2021 Virtual Spring Senior Executives Conference: The Future of Vaccine Development
Details
The Spring Senior Executives Meeting s one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
This Spring’s program will be virtual over four Thursdays in May and will discuss Pandemics and Infectious Diseases — a timely topic.
Thursday, May 20
11:00 AM – 12:30 PM Eastern US
The Future of Vaccine Development
Presented by:
- Philip Dormitzer M.D., Ph.D., Vice President and Chief Scientific Officer: Viral Vaccines, Pfizer
- Dr. Penny Heaton, CEO of the Bill & Melinda Gates Medical Research Institute
Dr. Dormitzer will share his and Pfizer’s perspective on COVID vaccine development and rollout, and how ALDA members can continue to contribute to similar efforts moving forward. Dr. Heaton will focus on the work of the Gates Foundation MRI and will discuss their collaborative efforts on battling infectious disease including tuberculosis & malaria and how the pandemic reaction and accelerated vaccine development will impact these efforts moving forward.
-
2021 Virtual Spring Senior Executives Conference: Closing Keynote--A Conversation with Michael Lewis
Details
The Spring Senior Executives Meeting s one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
This Spring’s program will be virtual over four Thursdays in May and will discuss Pandemics and Infectious Diseases — a timely topic.
Thursday, May 27
11:00 AM – 12:30 PM Eastern US
Closing Keynote: A Conversation with Michael Lewis: A Pandemic Story
Presented by:
- Michael Lewis, best-selling author of modernclassics including “Moneyball”, “The Blind Side”, “The Big Short”, “Liar’s Poker” and the upcoming “The Premonition: A Pandemic Story” coming out May 4. (Conference attendees will receive a copy of the book prior to the session.)
A summary of Lewis’ forthcoming best-seller:
“The news out of China was not good: there were signs that a new disease might be big—scary big, like a brushfire coming at you uphill. Authorities, medical and political, saw no reason to worry and little need for tests. Michael Lewis’s riveting nonfiction thriller pits a rogue band of visionaries, working under the radar, against the weight and disinterest of officialdom. It is a race against time, and the deadline is now … or yesterday.”
Join us, read your complimentary copy of the book, and ask questions of this dynamic author at the ALDA Senior Executive Conference.
**All individuals who register for this session will receive an email from ALDA in early April requesting a preferred mailing address for the book, however there is a limit of 150 total books, and we will distribute them to the first 150 responses we receive.
-
Breakfast at ECCMID 2021 **Tentative
VIenna, Niederösterreich
Details
The breakfast presents a great opportunity to meet and network with other senior executives from our members and invited guests attending the ECCMID 2021 Conference and Show.
In addition to networking, we bring in a guest speaker. Please note: ECCMID has changed the dates of the Conference to July 9-12, 2021. We will have a firm date shortly. - -
2021 Senior Management Conference
Laguna Beach, California
Details
The Fall Senior Management Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.
Past meetings have focused on the future of immunology, digital and the implications for health (assessing the use of artificial intelligence and machine learning in healthcare, blockchain technology and IoT), and how the ‘omics technologies are evolving (genomics, proteomics and metabolomics). We include a global economic and financial outlook to complement each topical program.
-
ALDA’s VIRTUAL 2021
Spring Senior Executives Conference will be
spread over four Thursdays in May, and the focus
will be on “Pandemics and Infectious Disease”
More Details
Welcome New Members!
We look forward to welcoming you in person, but until then we have several new member video introductions.
More Details
Member Testimonials
Recent Newsletter
Meet Our Members
Membership is open to companies with a life science, analytical, and diagnostics technology business.
These companies include manufacturers and suppliers of:
- Analytical Instruments, Reagents, and Consumables
- Lab Automation Tools
- Life Science Instrumentation, Reagents, and Consumables
- Software and Informatics – pure play sales force software
- Clinical Invitro & Advanced Diagnostics
ALDA meetings, market data, and surveys are tailored specifically for CEOs, presidents, and senior executives of member companies.
Dues are based on the member company’s global analytical, life science, and diagnostics business revenues for the most recent business year. Companies that are the U.S. or North American division of an overseas corporation can choose to pay dues based on their global revenues or their North American business revenues.
In addition to the annual dues members pay registration fees for attendees at some meetings. For most member companies that is estimated to average between $5-7K USD per year.
“Diagnostics” business refers to revenues from: molecular diagnostics; companion diagnostics; and emerging and next generation diagnostic technologies such as cellular diagnostics.
| Annual Revenues (in US Dollars) | Annual Dues |
|---|---|
| Under $10 million | $2,625 |
| $10-15 million | $4,725 |
| $15-25 million | $6,825 |
| $25-50 million | $10,500 |
| $50-100 million | $15,750 |
| $100-200 million | $21,000 |
| $200-300 million | $26,250 |
| $300-750 million | $31,500 |
| Over $750 million | $33,000 |
ALDA meetings, market data and surveys are directed to CEOs, presidents, and members of their senior executive teams. Most members agree that the most important membership benefit is the opportunity to regularly meet, have dialog, and develop strategic business relationships with others.
Senior Executives Meetings
Semi-annual meetings focus on timely topics and feature world-class speakers who offer strategic insights into trends, emerging technologies, and new markets. Leading business-school academics and industry consultants provide keynote presentations.
The Spring Meeting is typically held in Boston on the first Sunday-Tuesday in May and our Fall Conference is held on the West Coast on the first Sunday-Tuesday in October.
Click here to view a sample program >
List of attendees from our most recent meeting. >
Recent ALDA Semi-annual Meeting Topics:
- 2019 Fall: Immunology
- 2019 Spring: Single Cell Biology
- 2018 Fall: Digital and the Transformation of Healthcare
- 2018 Spring: Synthetic Biology
- 2017 Fall: Connection/Integration of ‘Omics Technologies
- 2017 Spring: Disruptive Forces – Sensors and Deep Learning
Other Meetings
- Annual Meeting for Senior Marketing & Sales Executives
- Annual Meeting for Senior Customer Service & Support Executives
- 2 Regional Senior Executive Dinners – one in Boston & one in the San Francisco Bay area
- Trade Show Breakfast Meetings which include AACC, AMP, Analytica, ECCMID, and SLAS
Powerful Networking
ALDA meetings offer opportunities to make valuable contacts and engage in dialogue. Increase your company’s visibility and gain valuable industry connections for business partnerships, OEM and sales opportunities, strategic investment, and mergers and acquisitions. In addition, trade show events and annual dinner meetings on both coasts make it easy to network with other industry executives, customers, and international organizations.
“ALDA brings together some of the brightest and most talented minds from both the life science and diagnostics space – it is a forum where we can truly interact and network with one and other in a way that no other industry association has enabled.”
Kamni Vijayena, Vice President and General Manager, Genomics Bio-Techne
Market Data
ALDA sponsors four market data reports.
1. The Industry Market Assessment Report is published quarterly and sent to all members of ALDA. The cost is included in your annual dues. The report contains a high level overview of the global market and 15 product/market segments, and is designed to complement your internal market research. Official and alternate representatives will automatically receive this report.
The following three reports are available only to participants:
2. The Global Lab Instruments Bookings Report tracks global bookings (orders) on a quarterly basis for about a dozen laboratory analytical instrument systems including LC, GC, LC-MS, GC-MS, UV/Vis, AA, FTIR and ICP products. ALDA jointly sponsors this report with instrument associations in Japan and Europe.
3. The Microplate Reader Sales Report tracks global sales on a semi-annual basis for three categories of microplate reader products: single-mode microplate readers, multi-mode microplate readers, and washers.
4. The Bio-Research Reagents Market Report tracks sales on a semi-annual basis for several categories of life science reagents and consumables. The report is offered on a subscription basis through the ABA Audits firm in the UK, and ALDA subsidizes a portion of the participation fee for our members.
Compensation Survey
ALDA members are invited to participate in the Pearl Meyer CHiPS One World Total Compensation Survey at the special fee of $995 USD. (2019)
The CHiPs One World survey reports positions based on salary, short-term and long-term incentives, total cash/target and direct compensation, and global merit increases.
Participants receive an all-participants report, a custom peer group report and an ALDA-only report, along with a full year of 24/7 access to CHiPs online with free on-demand features.
The CHiPS One World also offers one-to-one account support through their dedicated team of account managers. This customized approach ALDA members go beyond the data to understand how the survey results apply to their organization and its unique compensation needs.
How to Join
If you are interested in learning more about the association or if you are ready to join please contact Kerrie Peterson our Director of Membership at kpeterson@thealda.org.
Click here for a printable list of our members >
A
B
C
H
M
N
P
- Pall Corporation, a Danaher Company
- Parker Hannifin
- Peak Scientific Instruments Ltd.
- PerkinElmer Inc.
- Persistent Systems
- PhamaFluidics
- PHC Holdings Corporation
- Planet Innovation
- Precision NanoSystems, Inc.
- PreOmics GmbH
- Presco Engineering
- Promega Corporation
- Protein Dynamic Solutions LLC
- Protein Metrics Inc.
- Purigen Biosystems, Inc.
S
Applicants for membership in ALDA must be actively engaged in the manufacture and/or supply of “analytical and life science systems” or “diagnostics”.
Please contact Kerrie Peterson, our Membership Director for more information at KPeterson@thealda.org or (703) 647-6214.
Thank you for your interest!
About Us
ALDA (Analytical, Life Science & Diagnostics Association) is a non-profit industry trade association for global companies that develop and market products and services used in life science research, drug discovery, QA/QC and food testing, and clinical and molecular diagnostics.
ALDA’s meetings, data and programs are directed to C-suite executives, presidents and senior executives of our member companies to help them to develop business strategies to grow their business.
Member companies range from the industry’s largest suppliers to medium-size and small pre-product companies. Together, our analytical and life science members account for more than 70 percent of the industry’s global revenues. Our diagnostics members manufacture and supply molecular diagnostics, companion diagnostics, and emerging and next-generation diagnostic technologies.
ALDA is headquartered in Alexandria, Virginia, USA.
ALDA members participate in the $70 billion life science, analytical & diagnostics tools market. Participating companies supply instrumentation, reagents, consumables, assays, and related services for life science research, drug discovery, food safety, QA & QC testing along with clinical and diagnostics testing.
Having deep insights in the life sciences enables ALDA members to connect life science research to clinical diagnostics and brings diagnostic solutions faster to market. This enables better diagnostics and helps more patients throughout the world.
Officers
R. Bradley Gray Chairman
President & CEO
NanoString Technologies, Inc.
Patrick Kaltenbach Vice Chair & Chair Elect
Incoming CEO
Mettler-Toledo
Briar Alpert Chairman Emeritus
Former President & CEO of BioTek, an Agilent Company
Mike Copps President & CEO
Board of Directors
Thierry Bernard
Chief Executive Officer
QIAGEN
Rainer Blair
President and Chief Executive Officer
Danaher Corporation
Robert G. Carson
Senior Vice President, Corporate Development
Waters Corporation
Anna Christensen
President and CEO
Magnetic Insight, Inc.
Peter Dansky
Chief Executive Officer
Agena Bioscience, Inc.
Mark D. Fischer-Colbrie
Chief Executive Officer
Strateos
Joydeep Goswami
Senior Vice President of Corporate Development and Strategic Planning
Illumina
Tim Harkness
Chief Executive Officer
Unchained Labs
Charles (Chuck) Kummeth
President & CEO
Bio-Techne Corporation
William A. Linton
Chairman & CEO
Promega Corporation
Jean Qiu
Chief Technology Officer
Nexcelom Bioscience LLC
Puneet Sarin
President
BD Biosciences
Prahlad Singh
Chief Executive Officer
PerkinElmer, Inc.
Dan Shine
Analytical Instruments Group President
Thermo Fisher Scientific Inc.
Jacob Thaysen
SVP & President, Life Sciences and Applied Markets Group
Agilent Technologies, Inc.
Eva van Pelt
Co-CEO and Chief Commercial Officer
Eppendorf AG
Achim von Leoprechting
Chief Executive Officer
Tecan AG
Meetings
All ALDA meetings feature strategic presentations and are designed to facilitate networking opportunities. Customers and users often attend these meetings and present insights about their evolving needs for our industry’s products and services.
ALDA offers four types of meetings:
- Semi-annual meetings for CEOs, presidents, and senior executives. These meetings focus on timely topics and feature world-class speakers who offer strategic insights into trends, emerging technologies, and new markets. Leading business-school academics and industry consultants provide keynote presentations. The Spring Meeting is typically held in Boston on the first Sunday-Tuesday in May and our Fall Conference is held on the West Coast on the first Sunday-Tuesday in October.
Click here to view a recent program >
Click here to view a list of our semi-annual meeting topics >
List of attendees from our most recent semi-annual meeting >
- An annual meeting for senior marketing and sales executives, and senior service and support executives
- Two regional senior executive dinners – one in Boston & one in the San Francisco Bay area
- Trade show breakfast meetings including AACC, AMP, Analytica, ECCMID, and SLAS
“ALDA meetings are a primary benefit of membership because they bring together leading executives who are important to the analytical, life sciences and diagnostics industry.”
Briar Alpert, former President & CEO, BioTek (now an Agilent company)
“While the meeting content focuses on learning more about the scientific trends (which) help us as leaders to stay current, the meetings help with networking and understanding the various companies and actors in the industry.”
Rainer Blair, President & Chief Executive Officer, Danaher Corporation
Market Data & Compensation Survey
When you join ALDA, you connect with comprehensive, current insight into the industry. ALDA produces four market data reports.
The Industry Market Assessment Report is delivered quarterly to all members, whereas specific market reports are provided to participating companies only. You will find more details on each report below.
Members use our reports to benchmark operations against industry data and averages and:
- Improve efficiency and performance
- Broaden their perspective on global users and markets
- Identify and track emerging trends
Industry Market Assessment Report
This quarterly report is designed specifically for senior executives and is delivered to all ALDA member companies.
It contains a high-level overview of the global market and 15 product sectors. Among the 15 product sectors are life science instruments and reagents, cell analysis, liquid chromatography, and mass spectroscopy and lab automation.
Global Lab Instrumentation Bookings Report
This is a quarterly report that covers bookings for multiple analytical product sectors. Bookings are divided into North America, Europe, Japan, China, India, Latin America, and rest of world (ROW).
Member companies must provide data in order to receive this report.
Sectors covered include:
- Total Laboratory Analytical Business
- Gas Chromatographs (GC)
- Gas Chromatograph-Mass Spectrometers (GC-MS)
- Liquid Chromatographs (LC)
- Liquid Chromatograph-Mass Spectrometers (LC-MS)
- Ultra Violet/Visible/Near Infrared Spectrophotometers (UV/Vis/NIR)
- Atomic Absorption Spectrometers (AA)
- Fourier Transform Infrared Instruments (FTIR)
- Total Organic Carbon Analyzers (TOC Analyzers)
- Fluorescence Spectrophotometers (FS)
- Inductively Coupled Plasma Systems (ICP)
- Inductively Coupled Plasma–Mass Spectrometers (ICP-MS)
Bio-Research Reagents Market Report
This semi-annual report is produced for ALDA by ABA Audits Ltd. of the United Kingdom and member companies must provide data in order to receive this report.
It covers sales of products in 14 groups, including:
- Genomics
- Proteomics
- Cell Research
- General Biochemicals
- Specialty Research
- Amplification & PCR
- Real Time
- Labeling & Detection
- Antibodies
- Protein, Enzymes & Peptides
- Inhibitors
- Substrates & Receptors
- Cell Research Kits & Specialty Kits
- Assay Kits
Microplate Reader Report
This report is issued semi-annually and member companies must provide data in order to receive this report.
It covers three product segments in a spreadsheet format and contains data for the current period and past historical periods.
Product groups addressed include:
- Single-mode: combining scintillation, fluorescence, and luminescence
- Multi-mode
- Washers
ALDA members are invited to participate in the Pearl Meyer CHiPS One World Total Compensation Survey at the special fee of $995 USD (2019).
The CHiPs One World survey will provide your company with accurate and comprehensive information at an affordable rate. All elements of the employee pay package are collected and reported, providing your company with the information needed to analyze your competitive position and compensation mix from a total compensation perspective.
Among the data to be reported for each position are base salary, short-term and long-term incentives, total cash/target and direct compensation, and global merit increases.
Participants will receive an all-participants report, a custom peer group report and an ALDA-only report, along with a full year of 24/7 access to CHiPs online with free on-demand features.
The CHiPS One World also offers one-to-one account support through their dedicated team of account managers. This customized approach will help you to go beyond the data to understand how the survey results apply to your organization and its unique compensation needs.
Even if your company participates in other compensation surveys, the ALDA-sponsored survey will provide valuable information that will allow you to “test” and compare the results of other surveys.
Participants’ data is typically collected during the Spring with final submissions due in early May and a July 1 publication of the final report.
This survey covers:
- Base salaries
- Incentive eligibility and pay
- Bonus compensation for each position
- Mix of base and incentive pay
- Compensation practices
- Salary administration
- Professional and managerial total compensation
- Data reported on a country-by-country basis
We recently launched our first Diversity & Inclusion Benchmarking Survey.
Diversity & Inclusion Benchmarking Survey — ALDA has identified—through its members, DEI Task Force, and collaborative efforts—areas where there is a lack of sufficient data in our industry for our member companies to know how they are performing relative to diversity and inclusion efforts. Many are making decisions without supporting data.
As such, ALDA launched our first annual ALDA Diversity & Inclusion Benchmarking Study late last year in partnership with Pearl Meyer, the highly respected compensation consultancy. The results were shared with our members who participated in February.
This confidential and anonymous survey aimed to address this lack of data, and benchmarked industry performance related to two primary areas:
- Diversity in the workplace
- Diversity and inclusion practices
This survey received responses from 45 member companies and includes representation data on ~265,000 employees. We are very pleased with the results, particularly because this is our first time ever conducting a survey like this. There is a clear appetite for this information in our industry, and we are excited to be able to provide this actionable data set through ALDA.
We are also building out a higher-level executive summary with a corresponding narrative to share with the industry, including non-participants. We expect that to be completed shortly.
We certainly aren’t an anomaly but there is clear opportunity for growth here within most of our individual companies. We will work together to make progress and will continue to work through ALDA to drive positive change. Our member companies need this data, and so does our industry. This will help ALDA as an association track how we are doing relative to other industries, in healthcare and otherwise. This will also help us, and our member companies, make strategic decisions.
ALDA is excited to drive this initiative; we hope you agree that this data will be of high value to the association, our industry, and most importantly to you, our members.
Contact Us
Have questions or concerns? Or just need more information from ALDA? Contact us today.
1800 Diagonal Road
Suite 600
Alexandria, VA 22314
703.647.6214
Have questions or concerns? Or just need more information from ALDA? Contact us today.